QHSLab, Inc.
QHSLab, Inc. (USAQ) Financial Performance & Income Statement Overview
Explore the financials of QHSLab, Inc. (USAQ), including yearly and quarterly data on income, cash flow, and balance sheets.
QHSLab, Inc. (USAQ) Income Statement & Financial Overview
Analyze QHSLab, Inc.’s USAQ earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $544285.00 | $473073.00 | $488587.00 | $315021.00 |
| Cost of Revenue | $179152.00 | $178628.00 | $220457.00 | $143122.00 |
| Gross Profit | $365133.00 | $294445.00 | $268130.00 | $171899.00 |
| Gross Profit Ratio | $0.67 | $0.62 | $0.55 | $0.55 |
| R&D Expenses | $79500.00 | $64811.00 | $42638.00 | $44519.00 |
| SG&A Expenses | $178515.00 | $181638.00 | $211888.00 | $175791.00 |
| Operating Expenses | $258015.00 | $246450.00 | $254525.00 | $220310.00 |
| Total Costs & Expenses | $455195.00 | $443106.00 | $474983.00 | $363432.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $39325.00 | $32857.00 | $32129.00 | $38226.00 |
| Depreciation & Amortization | $36644.00 | $18028.00 | $36644.00 | $36644.00 |
| EBITDA | $125733.00 | $29967.00 | $31633.00 | -$11767.00 |
| EBITDA Ratio | $0.23 | $0.06 | $0.10 | -$0.04 |
| Operating Income | $89090.00 | $29967.00 | $13600.00 | -$48410.00 |
| Operating Income Ratio | $0.16 | $0.06 | $0.03 | -$0.15 |
| Other Income/Expenses (Net) | -$39325.00 | -$32857.00 | -$32129.00 | -$38226.00 |
| Income Before Tax | $49765.00 | -$2890.00 | -$18525.00 | -$86637.00 |
| Income Before Tax Ratio | $0.09 | -$0.006 | -$0.04 | -$0.28 |
| Income Tax Expense | $0.00 | $0.00 | -$4.00 | -$4.00 |
| Net Income | $49765.00 | -$2890.00 | -$18525.00 | -$86637.00 |
| Net Income Ratio | $0.09 | -$0.006 | -$0.04 | -$0.28 |
| EPS | $0.005 | -$0.00 | -$0.002 | -$0.009 |
| Diluted EPS | $0.003 | -$0.00 | -$0.002 | -$0.009 |
| Weighted Avg Shares Outstanding | $10.49M | $10.22M | $9.88M | $9.74M |
| Weighted Avg Shares Outstanding (Diluted) | $18.54M | $10.22M | $9.88M | $9.74M |
The company's financials show resilient growth, with revenue advancing from $315021.00 in Q4 2023 to $544285.00 in Q3 2024. Gross profit remained healthy with margins at 67% in Q3 2024 compared to 55% in Q4 2023. Operating income hit $89090.00 last quarter, sustaining a consistent 16% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $125733.00. Net income rose to $49765.00, while earnings per share reached $0.005. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan